What is a clinical trial EMA?
What is a clinical trial EMA?
The European Medicines Agency (EMA) relies on the results of clinical trials carried out by pharmaceutical companies to reach its opinions on the authorisation of medicines. It also manages a database of clinical trials carried out in the European Union (EU).
What is a CTA clinical trial application?
A Clinical Trials Application (CTA) is the application/submission to the competent National. Regulatory Authority(ies) for authorization to conduct a clinical trial in a specific country. Examples of.
What is a clinical trial application in Europe?
A streamlined application procedure for all clinical trials conducted in Europe via a single EU portal and database. All applicants must be registered before assessment. A single authorisation procedure for all clinical trials, to allow a faster and more thorough assessment by all concerned EU countries.
What are the applications of clinical trials?
A Clinical Trial Application provides comprehensive information about the investigational medicinal product(s) and planned trial, enabling regulatory authorities to assess the acceptability of conducting the study.
What is a Susar in clinical trials?
Suspected Unexpected Serious Adverse Reaction is the term used to refer to an adverse event that occurs in a clinical trial subject, which is assessed by the sponsor and or study investigator as being unexpected, serious and as having a reasonable possibility of a causal relationship with the study drug.
How many clinical trials are conducted in the EU annually?
4000 clinical trials
Approximately 4000 clinical trials of medicines are authorised annually in the European Union (EU).
What is an EU CTA?
The new Clinical Trial Regulation focuses on facilitating the Clinical Trial Application (CTA) process across all the EU Member States by streamlining submissions and approvals. The application of the new Regulation depends on the full functionality of the Clinical Trial Information System (CTIS).
What are the benefits of the EU CTR?
improved collaboration, information-sharing and decision-making between and within Member States; increased transparency of information on clinical trials; highest standards of safety for all participants in EU clinical trials.
How do you know if you are a SUSAR?
An SAE that occurs during research with a medicinal product is a SAR if there is a certain degree of probability that the SAE is a harmful and undesired reaction to the investigational medicinal product, regardless of the administered dose. If the SAR is unexpected it is called a SUSAR.
What is the EMA clinical trials information system?
EMA is delivering an online modular training programme to help clinical trial sponsors, national competent authorities, ethics committees, European Commission and EMA staff prepare for using the Clinical Trials Information System (CTIS).
How to apply for a clinical trial in Europe?
EU Clinical Trials Application Process. One of the major changes the EU Clinical Trial Regulation2 will introduce is a new clinical trial (CT) application procedure. Under the Regulation, Sponsors will be required to apply, via a new EU portal for authorisation to conduct an interventional clinical trial with medicines in Europe.
What does the European Medicines Agency ( EMA ) do?
EMA’s Committee for Medicinal Products for Human Use ( CHMP) is responsible for conducting the assessment of a human medicine for which an EU-wide marketing authorisation is sought. As part of its scientific evaluation work, the CHMP reviews the clinical trial data included in the application.
Where does the authorisation of clinical trials take place?
Although the authorisation of clinical trials occurs at Member State level, the Agency plays a key role in ensuring that the standards of good clinical practice (GCP) are applied across the European Economic Area (EEA) in cooperation with the Member States.
